drugset / Trial / NCT06684028

PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors

NCT06684028 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.

Timeline

Start
2023-07-12
Primary completion
2025-07-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-FAPI-JNU Diagnostic / imaging agent 2 mbq Intravenous
Subject 68Ga-FAPI-JNU Diagnostic / imaging agent 5 mbq Intravenous

Indications